172 related articles for article (PubMed ID: 35250865)
21. Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study.
Li X; Zhang H; Zhou Y; Cheng R
World J Surg Oncol; 2021 Apr; 19(1):138. PubMed ID: 33941214
[TBL] [Abstract][Full Text] [Related]
22. Risks of central lymph node metastasis in papillary thyroid carcinoma with or without multifocality in at least one lobe: A multi-center analysis.
Heng Y; Yang Z; Lin J; Liu Q; Cai W; Tao L
Oral Oncol; 2022 Nov; 134():106185. PubMed ID: 36191477
[TBL] [Abstract][Full Text] [Related]
23. Preoperatively Predicting the Central Lymph Node Metastasis for Papillary Thyroid Cancer Patients With Hashimoto's Thyroiditis.
Min Y; Huang Y; Wei M; Wei X; Chen H; Wang X; Chen J; Xiang K; Feng Y; Yin G
Front Endocrinol (Lausanne); 2021; 12():713475. PubMed ID: 34367075
[TBL] [Abstract][Full Text] [Related]
24. Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: Significant role of HBME-1.
Jianming L; Jibin L; Linxue Q
Eur J Radiol; 2020 Feb; 123():108801. PubMed ID: 31918249
[TBL] [Abstract][Full Text] [Related]
25. Nomogram based on preoperative conventional ultrasound and shear wave velocity for predicting central lymph node metastasis in papillary thyroid carcinoma.
Zhong L; Xie J; Shi L; Gu L; Bai W
Clin Hemorheol Microcirc; 2023; 83(2):129-136. PubMed ID: 36213990
[TBL] [Abstract][Full Text] [Related]
26. Nodal status of central lymph nodes as a negative prognostic factor for papillary thyroid carcinoma.
Lee YS; Lim YS; Lee JC; Wang SG; Kim IJ; Son SM; Shin DH; Lee BJ
J Surg Oncol; 2013 Jun; 107(7):777-82. PubMed ID: 23640873
[TBL] [Abstract][Full Text] [Related]
27. Using Diffusion-Weighted MRI to Predict Central Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Feasibility Study.
Zhang H; Hu S; Wang X; Liu W; He J; Sun Z; Ge Y; Dou W
Front Endocrinol (Lausanne); 2020; 11():326. PubMed ID: 32595598
[No Abstract] [Full Text] [Related]
28. Predictive Factors of Central-Compartment Lymph Node Metastasis for Clinical N0 Papillary Thyroid Carcinoma With Strap Muscle Invasion.
Xue S; Zhang L; Pang R; Wang P; Jin M; Guo L; Zhou Y; Dong B; Chen G
Front Endocrinol (Lausanne); 2020; 11():511. PubMed ID: 33013682
[No Abstract] [Full Text] [Related]
29. Risk factors of central lymph node metastasis in cN0 papillary thyroid carcinoma: a study of 529 patients.
Liang K; He L; Dong W; Zhang H
Med Sci Monit; 2014 May; 20():807-11. PubMed ID: 24831428
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.
Lin X; Chen X; Jiru Y; Du J; Zhao G; Wu Z
Bull Cancer; 2016 Jun; 103(6):535-40. PubMed ID: 27236850
[TBL] [Abstract][Full Text] [Related]
31. Papillary Thyroid Microcarcinoma: A Nomogram Based on Clinical and Ultrasound Features to Improve the Prediction of Lymph Node Metastases in the Central Compartment.
Ye J; Feng JW; Wu WX; Hu J; Hong LZ; Qin AC; Shi WH; Jiang Y
Front Endocrinol (Lausanne); 2021; 12():770824. PubMed ID: 35095755
[TBL] [Abstract][Full Text] [Related]
32. The Value of Ki-67 Labeling Index in Central Lymph Node Metastasis and Survival of Papillary Thyroid Carcinoma: Evidence From the Clinical and Molecular Analyses.
Lei Y; Zhao X; Feng Y; He D; Hu D; Min Y
Cancer Control; 2023; 30():10732748231155701. PubMed ID: 36744396
[TBL] [Abstract][Full Text] [Related]
33. [Application of Ultrasound Model for Predicting Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma].
Tian X; Luo Y; Zhang Y; Song Q; Ren L; Zhang Y; Jiang B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Oct; 42(5):626-631. PubMed ID: 33131517
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of a nomogram for preoperative prediction of ipsilateral cervical central lymph node metastasis in papillary thyroid cancer: a population-based study.
Zhao D; Li W; Zhang X
Gland Surg; 2024 Apr; 13(4):528-539. PubMed ID: 38720676
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of risk factors for central lymph node metastasis in papillary thyroid microcarcinoma].
Wang ZH; Zhang YJ; Fu GM; Chen YB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):12-17. PubMed ID: 30704163
[No Abstract] [Full Text] [Related]
36. Thyroid Antibody Status is Associated with Central Lymph Node Metastases in Papillary Thyroid Carcinoma Patients with Hashimoto's Thyroiditis.
Wen X; Wang B; Jin Q; Zhang W; Qiu M
Ann Surg Oncol; 2019 Jun; 26(6):1751-1758. PubMed ID: 30937662
[TBL] [Abstract][Full Text] [Related]
37. Nomogram for Preoperative Estimation of Cervical Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma.
Sun J; Jiang Q; Wang X; Liu W; Wang X
Front Endocrinol (Lausanne); 2021; 12():613974. PubMed ID: 33868164
[TBL] [Abstract][Full Text] [Related]
38. Risk factors of central lymph node metastasis in papillary thyroid carcinoma: A retrospective cohort study.
Tang T; Li J; Zheng L; Zhang L; Shi J
Int J Surg; 2018 Jun; 54(Pt A):129-132. PubMed ID: 29723673
[TBL] [Abstract][Full Text] [Related]
39. A prediction model incorporating the BRAF
Liu S; Liu C; Zhao L; Wang K; Li S; Tian Y; Jiao B; Gui Z; Yu T; Zhang L
Eur J Surg Oncol; 2021 Nov; 47(11):2774-2780. PubMed ID: 34483032
[TBL] [Abstract][Full Text] [Related]
40. [Risk factors for central neck lymph node metastases of papillary thyroid carcinoma].
Sun YS; Lyu HJ; Zhao YR; Zhang SS; Bai YX; Shi BY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):421-425. PubMed ID: 28635213
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
